iShares International Small?Cap Equity Factor ETF (ARCA: ISCF)

Latest news for iShares International Small?Cap Equity Factor ETF (ARCA:ISCF)

iShares Edge MSCI Intl Size Factor ETF

iShares FactorSelect MSCI Intl Small-Cap ETF

Industrials

Consumer Cyclical

Financial Services

Technology

Basic Materials

Real Estate

Consumer Defensive

Healthcare

Energy

Communication Services

Other

Utilities

The Fund seeks to track the investment results of the MSCI World ex USA Small Cap Diversified Multiple-Factor Index (the Underlying Index), The Fund generally will invest at least 80% of its assets in the component securities of its Underlying Index and in investments that have economic characteristics that are substantially identical to the component securities of its Underlying Index (i.e., depositary receipts representing securities of the Underlying Index) and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, including shares of money market funds advised by BFA or its affiliates, as well as in securities not included in the Underlying Index, but which BFA believes will help the Fund track the Underlying Index. 

Banco De Sabadell Sa

Swissquote Group Holding Sa

Bank of Ireland Group Plc

Vat Group Ag

Toho Gas Co Ltd

Celestica, Inc

The British Land Company Plc

Be Semiconductor Industries

iShares International Small-Cap Equity Factor ETF

Broad U.S. Equity ETFs

New ETFs

Trading Ideas

ETFs

AAPL

ACWF

GILD

INTF

ISCF

LRGF

MSFT

SMLF

iShares Rolls Out New Smart Beta ETFs

iShares International Small?Cap Equity Factor ETF

<a href="https://www.globenewswire.com/Tracker?data=r4RuL-g8BiKVZqLRnMl8EGgAMp3MEvcuP1lhTYpiuoJgsZ1jahk_eeysIWLnQ1bAlIACdbq5BXPKTE0CscTH9fs6bHnXyXzwYWhIPkSFsL0=">Black Diamond Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDTX#NASDAQ">BDTX</a>), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today reported initial Phase 2 data demonstrating encouraging clinical responses and durability of BDTX-1535 in patients with relapsed/refractory epidermal growth factor receptor (EGFR)-mutant (EGFRm) non-small cell lung cancer (NSCLC).
"Patients often become resistant to osimertinib with the emergence of on-target resistance EGFR mutations," said Sergey Yurasov, M.D., Chief Medical Officer of Black Diamond Therapeutics. "Our preliminary Phase 2 data demonstrate the potential of BDTX-1535 to deliver durable responses for these patients."
"Patients with recurrent EGFRm NSCLC have few treatment options, with chemotherapy delivering limited benefit and significant toxicity, and initial Phase 2 data with BDTX-1535 look quite promising," said Danny Nguyen, M.D., <a href="https://www.globenewswire.com/Tracker?data=vlr3UZ7jREPq-nVuV_0_0C88uBRItoG_u2Pds2FLZhl6OdG7j4DTPUFysQY2y_LIjwyzqAqfOfpni53hE75snJRWUiN0k0RirbHBhXGxPKYSET-VNVVUwbCm2cnWyEzenhj0xWJvWFDh1oHU2wzxnXLBK7T4WBCokjmhe7dQL7lQDcWhMG63hpBMKrSRhrsiyEiYvQrw6wRSj8xyaeufaSI2us8FlQDhdtCYWaPgkus=">Assistant Clinical Professor, Department of Medical Oncology and Therapeutics Research at City of Hope</a>. "There is a significant unmet medical need for an effective and well-tolerated oral therapy for patients who progress on osimertinib, as well as newly diagnosed patients with non-classical mutations."
Phase 2 preliminary data overview:
The phase 2 trial began in August of 2023, and enrolled relapsed/refractory patients with non-classical EGFR mutations (NCMs) (Cohort 1) and those with C797S resistance mutations (Cohort 2). Safety assessment and dose selection were based upon the first 40 patients randomized to receive BDTX-1535 once daily at either 100 mg or 200 mg across both Cohorts. Preliminary response rate and durability were assessed in 27 patients at 200 mg with an August 17, 2024, data cutoff, including 22 response-evaluable patients who met protocol eligibility criteria.
Key takeaways:
<ul>
<li>200 mg daily selected for pivotal clinical development. Dose selection was based primarily on pharmacokinetics, safety and tolerability data from 20 patients at 100 mg, and 20 patients at 200 mg.</li>
<li>Favorable tolerability profile at 200 mg, consistent with prior BDTX-1535 clinical data. The majority of adverse events were mild or moderate, and no new safety signals were observed. The most common on-target treatment-related adverse events were rash (70%) and diarrhea (35%). There were 2 cases of grade 3 rash, and no reported cases of grade 4 rash or grade 3/4 diarrhea.</li>
<li>Preliminary objective response rate (ORR) of 42% achieved in 19 patients. For the 22 response-evaluable patients, the preliminary ORR was 36%. Nineteen of these 22 patients expressed known osimertinib resistance mutations: either C797S or P-loop alpha-C helix compressing (PACC, a major subset of NCMs). Of these 19 patients, 8 achieved a response (42%): 5 with a confirmed partial response (PR), including 1 patient who converted from a PR to an unconfirmed complete response (CR) at 8 months (and awaits confirmatory scan); and 3 with an unconfirmed PR at first scan and awaiting a confirmatory scan. An additional 9 patients experienced stable disease.</li>
<li>Encouraging durability observed, with duration of response (DOR) of approximately 8 months or more for first 3 patients with PR; 14 of 19 patients remain on therapy. Mean follow-up time is 4.7 months.</li>
</ul>
"We are pleased to see significant Phase 2 clinical activity and tolerability that are consistent with our Phase 1 results," said Mark Velleca, M.D., Ph.D., Chief Executive Officer of Black Diamond Therapeutics. "We believe that the activity observed in the recurrent setting can translate to robust clinical benefit in the first-line setting, and we look forward to sharing data from our trial in newly diagnosed patients in Q1 2025."
Black Diamond continues to enroll patients in the second- and third-line cohorts, as well as in the first-line setting for patients with non-classical EGFR mutations. In Q1 2025, the Company expects to disclose initial results from the first-line cohort and to outline potential registrational paths in the recurrent setting based on FDA feedback.

Government

News

Regulations

BDTX

Black Diamond Reports Phase 2 Results for BDTX-1535 in Lung Cancer, Targets FDA Approval Path

Lead investors, Delta Air Lines, Inc.,&nbsp;CK&nbsp;Wheels&nbsp;LLC, and Cox&nbsp;Investment Holdings,&nbsp;LLC, agreed to extend the lock-up restriction with respect to all their shares of common stock&nbsp;issued under the Investment and Investor Rights Agreement, for an additional year, until September&nbsp;20,&nbsp;2025.
In addition, Kore Capital LLC and funds managed by Whitebox&nbsp;Advisors LLC, agreed to extend the lock-up restriction with respect to&nbsp;72.5%&nbsp;of their shares until September&nbsp;20,&nbsp;2025.

Wheels Up Says Approximately 97.2% Of Lead Investor Shares Will Remain Subject To The Lock-up Restriction Until September 20, 2025

AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>), the world's trusted infrastructure consulting firm, today announced its selection by the City of Austin as the prime consultant for the expansion of the Walnut Creek Wastewater Treatment Plant (WWTP) in Austin, Texas. The project aims to improve the aging structure's operational and environmental features by increasing the plant's capacity from 75 million gallons per day (MGD) to 100 MGD. As the population of Austin grows, the upgrades will bolster the resiliency of the community's wastewater infrastructure while safeguarding its surrounding ecosystem.
"As our industry's leading Water consulting firm, we look forward to continuing our long-standing partnership with the City of Austin to ensure the Walnut Creek Expansion delivers state-of-the-art treatment capabilities to the local community," said Beverley Stinson, chief executive of AECOM's global Water business. "Our teams have established themselves as pioneers in the global push to advance highly efficient and cost effective nutrient removal, and will leverage this extensive expertise to enhance the plant and improve the effluent water quality to protect the environment, while meeting existing and future community demands."
The AECOM team's scope of work for the project includes process, mechanical, civil, electrical and structural engineering services to modernize and upgrade the existing infrastructure, while incorporating advanced operational and environmental features. The expansion will involve replacing aging equipment, constructing a new 25 MGD treatment train, and building a new 120-inch outfall line and structure. The project will also provide wet weather treatment with new 100 MGD cloth filters and build a flood wall to protect against 100-year floods in accordance with the National Weather Service's historic <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.austintexas.gov%2Fdepartment%2Fflood-risk-and-atlas-14&amp;esheet=54125161&amp;newsitemid=20240923628017&amp;lan=en-US&amp;anchor=Atlas+14&amp;index=1&amp;md5=f42d51c75c9b61534bc111d8082f631f">Atlas 14</a> flood risk study.
"AECOM has a longstanding partnership with the City of Austin, having designed substantial portions of the City's major water and wastewater treatment plants," said Matt Crane, chief executive of AECOM's U.S. West region. "Our expertise in complex treatment design will support an exceptionally resilient, sustainable facility, aligning with our Sustainable Legacies strategy to make a lasting positive impact through every project we undertake."
Originally built in 1977 with an 18 million gallon per day capacity, the Walnut Creek Wastewater Treatment Plant has since been expanded three times in 1987, 1990, and 2005 to reach its current capacity of 75 million gallons per day. The facility is expected to remain operational throughout the work.

AECOM to Lead Major Expansion of Austin's Walnut Creek Wastewater Plant, Boosting Capacity to 100 MGD

Tempur Sealy International, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPX#NYSE">TPX</a>, ", Company", or ", Tempur Sealy", )))) today provided an update with respect to the Company's agreement to acquire Mattress Firm Group Inc. ("Mattress Firm"), which is currently being challenged in federal court by the Federal Trade Commission ("FTC").
The litigation process continues to progress, with hearings currently scheduled to begin on November 12, 2024, and expected to last two weeks. The Company continues to believe that a successful litigation process can be completed in the coming months, which would allow the transaction to close in late 2024 or early 2025, consistent with previous expectations.
In conjunction with the planned Mattress Firm acquisition, Tempur Sealy has entered into a purchase agreement with MW SO Holdings Company, LLC ("Mattress Warehouse"), a leading independently owned bedding specialty retailer, for the sale of 73 Mattress Firm retail locations and the Company's Sleep Outfitters subsidiary, which includes 103 specialty mattress retail locations and seven distribution centers.
Mattress Warehouse is a multi-branded retailer offering a full array of mattresses at various price points. Tempur Sealy will continue to supply its Tempur-Pedic, Stearns &amp; Foster, and Sealy products to the divested Mattress Firm and Sleep Outfitters stores. The divestiture is subject to the closing of Tempur Sealy's acquisition of Mattress Firm and other customary closing conditions. It is expected to close approximately one quarter after the closing of the Mattress Firm transaction.
Company Chairman and CEO Scott Thompson commented, "As part of our engagement with the FTC on the proposed acquisition of Mattress Firm, we conducted a divestiture process, which led to an agreement with Mattress Warehouse, a company with extensive mattress retail experience, a strong capital base, and a capable leadership team."

Tempur Sealy Moves Forward with Mattress Firm Acquisition, FTC Court Hearings Set for November

Tempur Sealy intends to use the proceeds from the Term Loan B, together with cash available and proceeds from other debt, to fund the cash consideration for the previously announced acquisition of Mattress Firm Group Inc.. Tempur Sealy intends to draw on the Term Loan B concurrent with the closing of the Mattress Firm acquisition.

Tempur Sealy Launches Proposed Senior Secured Term Loan B Facility In An Aggregate Principal Amount Of Up To $1.6B

Keybanc analyst Jackson Ader maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Overweight and raises the price target from $300 to $345.

Price Target

Analyst Ratings

CRWD

Keybanc Maintains Overweight on CrowdStrike Holdings, Raises Price Target to $345

Keybanc analyst Sangita Jain maintains Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) with a Overweight and raises the price target from $230 to $265.

Keybanc Maintains Overweight on Constellation Energy, Raises Price Target to $265

Keybanc analyst Steve Barger maintains Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) with a Overweight and raises the price target from $215 to $245.

Keybanc Maintains Overweight on Applied Industrial Techs, Raises Price Target to $245

The&nbsp;Committee for Medicinal Products for Human Use (CHMP)&nbsp;of the European Medicines Agency based its positive opinion on results from the MANDARA Phase III trial published in&nbsp;The New England Journal of Medicine, which compared the efficacy and safety of&nbsp;Fasenra&nbsp;to the only approved EGPA treatment, mepolizumab, in patients with relapsing or refractory EGPA.
MANDARA was the first head-to-head non-inferiority trial of biologics in patients with EGPA. Patients were randomized to receive either a single 30 mg subcutaneous injection of&nbsp;Fasenra, or three separate 100 mg subcutaneous injections of mepolizumab every four weeks.

Biotech

Large Cap

Health Care

General

AstraZeneca's Fasenra (Benralizumab) Has Been Recommended For Approval In The European Union As An Add-on Treatment For Adult Patients With Relapsing Or Refractory Eosinophilic Granulomatosis With Polyangiitis

SpaceX CEO Elon Musk said on Monday that there are <a href="https://www.benzinga.com/news/24/09/40967983/spacex-pushes-ahead-with-fifth-starship-test-flight-preparation-despite-no-faa-launch-approvals-in-s">multiple regulatory hurdles</a> to launching a rocket, including getting clearance from the U.S. Fish and Wildlife Service.
What Happened: &#8220;We need multiple Fish licenses to launch a rocket (actually)!,&#8221; Musk wrote on social media platform X, referring to clearance from the United States Fish and Wildlife Service required ahead of space missions confirming that the operations will not impact surrounding wildlife.
The CEO was responding to a snippet of his interview with Lex Fridman from November 2023 where he said, &#8220;Currently, the limiting factor for SpaceX, for Starship launch, is regulatory approval.&#8221;
&#8220;I don&#8217;t think the public is quite aware of the madness that goes on,&#8221; Musk then said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We need multiple Fish licenses to launch a rocket (actually)! <a href="https://t.co/K9zj0EqyTZ">https://t.co/K9zj0EqyTZ</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1838089797224497250?ref_src=twsrc%5Etfw">September 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Earlier this month, SpaceX said in a blog post that the delay in getting regulatory approvals for the fifth test flight of its ambitious Starship, despite the launch vehicle being ready, is because the Federal Aviation Administration is consulting with the U.S. Fish and Wildlife on the impact of the proposed flight on surrounding wildlife, among other reasons. 
On Sunday, Musk also raised concerns about the Starship program getting &#8220;smothered&#8221; by government bureaucracy. The bureaucracy is rising and the regulatory red tape is affecting all large projects in America, the CEO said. 
The regulations, Musk previously said, <a href="https://www.benzinga.com/news/24/09/40812203/elon-musk-warns-spacexs-efforts-to-make-life-multiplanetary-would-be-effectively-illegal-without-maj">will intensify </a>if Kamala Harris is elected President in the upcoming elections. While Republican Donald Trump has expressed willingness to initiate a government efficiency commission aimed at reducing regulations, the red tape would only rise under a Democratic party administration, Musk opined.
Why It Matters: Musk on Sunday also said that SpaceX intends to launch about five uncrewed Starships to Mars in two years, elaborating on his timeline from earlier this month.
If the five uncrewed missions land safely, crewed missions will be&nbsp;<a href="https://www.benzinga.com/news/24/09/40972893/trumps-mars-landing-promise-gets-slammed-by-peter-schiff-even-as-elon-musk-says-spacex-plans-5-launc" target="_blank" rel="noreferrer noopener">possible in four years</a>, Musk said. However, in case of challenges, the crewed missions will be postponed another two years, he added, pegging crewed Starship missions to Mars for as early as 2028 and latest by 2030.
However, the Starship has undergone only four test flights to date, and Musk has previously made tall claims about the Starship&#8217;s readiness. Musk aims to take humans to Earth&#8217;s orbit, the Moon, and Mars with the spacecraft. 
However, Musk&#8217;s SpaceX has been increasing its launch frequency with its Falcon launch vehicles alone. Earlier this month, the company launched its <a href="https://www.benzinga.com/news/24/09/40916098/elon-musks-spacex-launches-90th-mission-in-2024-with-over-a-third-of-launch-target-still-to-go">90th mission for the year</a> with its Falcon 9 workhorse accounting for a majority of the launches. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="ttps://www.benzinga.com/news/24/09/40973892/unifor-members-at-gms-cami-assembly-and-battery-assemble-plants-secure-new-contract-with-pay-increas">Unifor Members At GM&#8217;s CAMI Assembly And Battery Assemble Plants Secure New Contract With Pay Increases</a></li>
</ul>
Image Via Shutterstock

SPACE

Tech

Elon Musk Shares It Takes 'Multiple Fish Licenses' To Launch A Rocket: 'I Don't Think The Public Is Quite Aware Of The Madness That Goes On,' Says SpaceX CEO

<a href="https://americanbatterytechnology.com/">&nbsp;American Battery Technology Company</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, has been <a href="https://www.energy.gov/mesc/bipartisan-infrastructure-law-battery-materials-processing-and-battery-manufacturing-recycling">selected for a highly competitive grant for $150 million</a> dollars of federal investment&nbsp;by the U.S. Department of Energy to be applied towards the construction of a new lithium-ion battery recycling facility.
&nbsp;
This facility will be the company's second commercial-scale lithium-ion battery recycling facility and is designed to process approximately 100,000 tonnes of battery materials per year from its battery manufacturer, automotive OEM, and community partners.
"We are extremely honored to be selected for this government investment to further expand our domestic battery recycling operations, and after having gone through nearly one-year of technical and economic evaluation, we appreciate the level of diligence that the government employed in making this decision," stated ABTC CEO Ryan Melsert. "We are greatly appreciative of the confidence and support we have received from our partners throughout this process and are energized to move forward with our feedstock supply, product offtake, and strategic stakeholders in this critical expansion of our domestic capabilities."
True to the company's strategic model to engage a diverse portfolio of partners and stakeholders to bring advanced battery technologies online and establish a commercial battery metals supply chain for North America, this project will leverage multiple partners including feedstock supplier and critical mineral product offtaker BASF, global engineering firm Siemens, the Clemson University International Center for Automotive Research (CU-ICAR), the Argonne National Laboratory (ANL) ReCell Center, the Argonne National Laboratory Sustainable Transportation Education &amp; Partnerships (STEP) department, and the South Carolina Electric Transportation Network (SCETNetwork). &nbsp;
ABTC constructed and commissioned its first lithium-ion battery recycling facility near Reno, Nevada in Fall 2023, which implements its internally-developed processes for the strategic de-manufacturing and targeted chemical extraction of battery materials in order to manufacture battery grade products at competitive costs and with low environmental footprint.&nbsp; These processes are fundamentally different than conventional methods of battery recycling, which generally utilize either high temperature smelting or non-strategic shredding systems.
Through this new facility construction project, ABTC will employ a proactive, community-driven engagement model to build an energy equity, sustainable circular manufacturing ecosystem that aims to create 1,200 construction jobs and 300 operations jobs. The company will work in direct partnership between communities, educational institutions, industry, government, the National Laboratory system, and the next generation workforce to support equitable and sustainable initiatives that benefit and strengthen in local communities, including in underserved communities that have historically been left behind.
ABTC is partnering with government entities and local educational institutions, such as ANL's STEP department and Clemson University, to create career pathways in battery recycling and establish a talent pipeline for the domestic battery recycling industry.
Bringing first-of-kind technologies to market,&nbsp;ABTC's battery recycling and primary battery metals commercialization efforts support the buildout of a domestically-sourced battery metals circular supply chain.&nbsp; ABTC has been selected for several competitive awards supporting the advancement and commercialization of its first-of-kind technologies for both battery recycling and primary claystone-to-lithium hydroxide manufacturing.&nbsp; &nbsp; U.S. DOE Investments in ABTC Lithium-Ion Battery Recycling&nbsp;
<ul>
<li>October 2021: ABTC was awarded a competitive grant for a <a href="https://americanbatterytechnology.com/projects/usabc-project/">$2 million project</a> from the United States Advanced Battery Consortium (USABC) supported by funding from US DOE to foster the recycling of battery packs and extraction of battery metals, with USABC cost contributions of $500k.</li>
<li>November 2022: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-from-us-doe-for-20m-project-to-accelerate-commercialization-of-next-generation-advanced-battery-recycling-technologies/">ABTC was awarded for a competitive grant for a $20 million project from the U.S. DOE to scale</a>, optimize, and commercialize three next generation technologies to even further enhance the performance of its recycling operations, with a federal contribution of $10 million.</li>
<li>March 2024:<a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-awarded-20-million-tax-credit-through-competitive-us-doe-process-to-advance-its-critical-minerals-battery-recycling-facility/"> ABTC awarded qualifying advanced energy project tax credits (48C) for $20 million</a> to be applied towards capital expenditures of its first battery recycling facility near Reno, Nevada.</li>
<li>March 2024: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-awarded-additional-40-million-competitive-tax-credit-to-accelerate-construction-of-next-battery-recycling-facility/">ABTC awarded qualifying advanced energy project tax credits (48C) for $40 million</a> to be applied towards capital expenditures of its second battery recycling facility.</li>
<li>TBD 2025: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-from-us-doe-for-20m-project-to-accelerate-commercialization-of-next-generation-advanced-battery-recycling-technologies/">ABTC was selected for this competitive grant for a $150 million project from the U.S. DOE to construct a second battery recycling facility</a>.</li>
</ul>
U.S. DOE Investments in ABTC Lithium Hydroxide (LiOH) from Claystone Manufacturing&nbsp;
<ul>
<li>October 2021: <a href="https://www.energy.gov/eere/ammto/advanced-manufacturing-office-fy20-critical-materials-foa-selections">ABTC was awarded a competitive grant supporting a $4.5 million project</a> from the U.S. DOE for the demonstration of its battery-grade lithium hydroxide production from Nevada claystone resources, with federal contributions of $2.27 million.</li>
<li>October 2022: <a href="https://americanbatterytechnology.com/press-release/american-battery-technology-company-receives-contract-for-57m-grant-from-us-doe-for-construction-of-commercial-scale-lithium-hydroxide-refinery/">ABTC was awarded a competitive grant supporting a $115 million project</a> from the U.S. DOE to construct a commercial-scale lithium hydroxide refinery, with a federal contribution of $57.7 million.</li>
</ul>
These battery recycling technologies were developed in-house by the ABTC R&amp;D, project management, and engineering team members, many of whom were previously members of the founding Tesla Gigafactory design and engineering teams. &nbsp;ABTC intends to utilize these significant experiences in collaboration with project partners to scale processes and bring first-of-kind commercial-scale facilities online and leveraging this expertise to de-risk ABTC's commercialization of this second battery recycling facility.
As ABTC has now completed the technical and economic evaluations and been selected for this competitive grant award, it will next enter the grant award contracting phase of this process with an expected project kickoff in 2025.

ABAT

American Battery Technology Secures $150M US DOE Grant, Expanding Battery Recycling Facility

Management

Owens & Minor Has Appointed Jonathan Leon As Executive Vice President And Chief Financial Officer, Effective Immediately

Lifezone Metals Limited's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LZM#NYSE">LZM</a>) Chief Executive Officer, Chris Showalter, is pleased to announce that Lifezone, in partnership with BHP, has formally commenced the project financing process for the Kabanga Nickel Project in Tanzania. In conjunction, Lifezone has received a Letter of Interest from the U.S. International Development Finance Corporation (DFC) that expressed DFC's interest in considering the Project for loans as part of the Project's financing package.
Tanzanian Minister of Minerals, Hon. Anthony Mavunde, welcomed the news, saying: "The Kabanga Nickel Project is a model example of the Government of Tanzania's commitment to fostering sustainable development and economic growth for the benefit of Tanzania and Tanzanians. We are delighted with the announcement that DFC has signed a Letter of Interest for project finance of Kabanga. Building on the 2023 visit to Tanzania by Vice President Harris, DFC's action shows that Tanzania and the United States continue to develop a strong economic partnership founded on a shared vision for sustainable development and we are looking forward to further developing our relationship to pursue our common goals. This project will not only boost our economy regionally and nationally, but also position Tanzania as a leading international player in the global nickel market, contributing significantly to the global energy transition."
Mr. Showalter also commented: "The initiation of the project financing process with Societe Generale is a crucial next step in securing the funding required for Kabanga, and is yet another indicator of the strategic importance of the Project to our global partners. With DFC's interest in supporting Kabanga, the U.S. government clearly recognizes the critical role that sustainable mineral development in Africa plays in the global energy transition. Today's announcement reinforces this vision and again highlights the strong relationship between the United States and Tanzania."
Scott Nathan, Chief Executive Officer of DFC added: "DFC is helping to advance the global energy transition through projects that drive sustainable development and economic growth. The Kabanga Nickel Project represents a significant opportunity to advance responsible mineral development in Tanzania, diversifying critical supply chains and fostering economic resilience in the region."
The DFC loan application would initiate a comprehensive review process; this follows <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fir.lifezonemetals.com%2Fnews%2Fpress-releases%2Fnews-details%2F2024%2FLifezone-Metals-Initiates-Process-for-Risk-Insurance-with-U.S.-International-Development-Finance-Corporation-for-the-Kabanga-Nickel-Project-in-Tanzania%2Fdefault.aspx&amp;esheet=54125613&amp;newsitemid=20240923733638&amp;lan=en-US&amp;anchor=Lifezone%26%238217%3Bs+August+27%2C+2024+announcement&amp;index=1&amp;md5=f757042432b47c95de66350df5fb940b">Lifezone's August 27, 2024 announcement</a> that DFC would be evaluating political risk insurance coverage for future investments in Kabanga.
Kabanga is one of the world's largest and highest-grade undeveloped nickel sulfide deposits. By utilizing Lifezone's Hydromet technology, the project is expected to significantly reduce emissions compared to traditional smelting methods.
Kabanga is supported by the Partnership of Global Infrastructure and Investment (PGI), which is a values-driven, high-impact, and transparent infrastructure partnership that was created to meet the enormous infrastructure needs of low- and middle-income countries and to support the United States' and its allies' economic and national security interests. Kabanga is also recognized as a project within the Minerals Security Partnership, a collaboration of 14 countries and the EU to catalyze public and private investment in responsible critical minerals supply chains globally.
DFC is America's development finance institution. It partners with the private sector to finance solutions to the most critical challenges facing the developing world today across sectors including energy, infrastructure, healthcare, agriculture, and financial services. DFC investments adhere to high standards and respect the environment, human rights, and worker rights.
Societe Generale appointed as lead financial advisor to Kabanga Nickel Limited
Societe Generale has been appointed as the lead financial advisor to Kabanga Nickel Limited, a subsidiary of Lifezone that is managed by Lifezone and in which BHP has a 17% interest.
Lenaig Trenaux, Global Head of Batteries, Mining and Industries, Societe Generale, commented: "Societe Generale supports its clients in the energy transition, through dedicated solutions, and a commitment to contribute to sustainable finance. We are very pleased to be working jointly with Lifezone Metals and BHP to deliver the Kabanga Nickel Project, aiming to foster development in Tanzania and feed the energy transition with a large volume of low carbon critical mineral."
Societe Generale brings world-leading expertise in large-scale debt financing for mining projects globally. In cooperation with BHP, Lifezone and Societe Generale will look to optimize Kabanga's capital structure through a combination of multi-source project-level debt and equity.

Lifezone Metals and BHP Begin Project Financing for Tanzania's Kabanga Nickel, Supported by US DFC

Benchmark analyst Cody Acree reiterates Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) with a Hold.

Reiteration

INTC

Benchmark Reiterates Hold on Intel

Needham analyst Mike Cikos reiterates Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Buy and maintains $28 price target.

CFLT

Needham Reiterates Buy on Confluent, Maintains $28 Price Target

Iris Energy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) (together with its subsidiaries, "IREN") today provided a business update. &nbsp;
"We are pleased to announce that we've reached our 20 EH/s milestone ahead of schedule. This achievement reflects the hard work of our global team. Thank you for your dedication and efforts in making this happen," said Daniel Roberts, Co-Founder and Co-CEO of IREN. "We look forward to continuing this momentum as we expand to over 30 EH/s in the next three months."
IREN achieves 20 EH/s milestone
IREN has increased its installed capacity to 20 EH/s (16 J/TH efficiency).
Through optimization of its existing data center infrastructure, IREN now expects to increase its installed capacity to 21 EH/s in the coming days.
On track for 31 EH/s in 4Q 2024
Childress Phase 3 (150MW) construction is well underway, with approximately 430 people mobilized to site.
As part of the expansion from 21 EH/s to 31 EH/s, previously purchased Bitmain S21 XP miners (13.5 J/TH) are scheduled for shipping over the next 2 months.
Based on 31 EH/s (15 J/TH efficiency):
<ul>
<li>$20k electricity cost per Bitcoin mined</li>
<li>$30k all-in cash cost per Bitcoin mined</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

IREN

Iris Energy Boosts Capacity to 20 EH/s, 31 EH/s Expected by End of 2024

TD Cowen analyst Oliver Chen downgrades Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) from Buy to Hold and announces $395 price target.

Downgrades

ULTA

TD Cowen Downgrades Ulta Beauty to Hold, Announces $395 Price Target

On September 20, 2024 the Board of Directors declared a quarterly cash dividend of 25.0 cents per share on the Company's common stock. The Board of Directors also approved a one-time special dividend of $2.50 per share.&nbsp;

Dividends

Ennis, Inc Declares $0.25 Quarterly Dividend, Approves Special $2.50 Payout

Strategic Synergies
The integration of Swifty is expected to bring several operational advantages and new revenue opportunities for Signing Day Sports:
<ul>
<li>Cost Efficiency: Swifty's in-house engineering team is expected to reduce Signing Day Sports' operating costs by over 50%, enabling the company to reinvest those savings into growth initiatives. It is also expected to increase the speed at which Signing Day Sports can roll out new products and technological enhancements to its current offering and optimize monetization of the product and user base.</li>
<li>Revenue Growth in SaaS: At their core, both Signing Day Sports and Swifty are SaaS model businesses. Swifty's scalability, technological resources, and technology initiatives are expected to bolster the growth of Signing Day Sports' app user base, enhance user retention and provide additional opportunities to monetize renewing subscribers with additional revenue streams.</li>
<li>New Revenue Streams: Swifty is expected to further expand Signing Day Sports' current product offering while also broadening the Company's exposure to new sports and athletes outside the U.S. Signing Day Sports has accumulated more than 10,000 registered users, which it plans to increase at an accelerated rate in the fourth quarter of 2024 and 2025. The Company's focus is to develop new strategic revenue streams, and improve revenue metrics per user, with the same aim of fully monetizing this growing user base.</li>
<li>New Market Exposure: Since its beginning as a football student-athlete recruitment platform provider, Signing Day Sports has expanded its platform to support baseball, softball, and men's and women's soccer. Swifty is expected to bring exposure to new markets in Europe, Africa and the Middle East, as well as exposure to emerging sports without established recruitment models. The Company anticipates that early adopters in these emerging sports markets are a significant market and plans to broaden its platform to capitalize on these prospective revenue streams.</li>
<li>Enhanced User Engagement: Swifty's team is expected to introduce exciting new features to Signing Day Sports, including gamification elements such as live scoreboards, top competitor leaderboards, fantasy leagues and real-time performance tracking, which are designed to boost engagement, organic user acquisition and user retention.</li>
</ul>

Signing Day Sports Provided An Update Regarding Its Financial Position And Its Plans To Acquire Dear Cashmere, Doing Business As Swifty Global, Highlighting The Strategic And Financial Synergies That Are Expected To Drive Accelerated Growth And Operational Efficiency For Both Companies

XOMA

ZVRA

XOMA Royalty Says Zevra Therapeutics Received FDA Approval For MIPLYFFA; Says It Is Entitled To Receive Mid-single Digit Royalty On MIPLYFFA Sales And Up To $52.6M In Milestones

Above The Noise: Anticipating A New Year And A New Market Environment

iShares MSCI Intl Small-Cap Multifactor ETF declares semi-annual distribution of $0.7308

VSS: Well-Ranked In The Global Small-Cap ETF Category

Q4 2023 - International Equity Review And Outlook

Asset Class Mean Reversion: 2024 Review And Outlook

AVDV: Value Meets Performance In International Small Caps

Looking Under The Hood Of Recent Global Small- And Large-Cap Performance

iShares MSCI Intl Small-Cap Multifactor ETF declares semi-annual distribution of $0.5690

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

iShares International Small?Cap Equity Factor ETF

News

Latest news for iShares International Small?Cap Equity Factor ETF (ARCA:ISCF)

Friday, May 08, 2015